Jesse Shefferman insider trades
Open-market stock purchases and sales by Jesse Shefferman, CEO and President at Protara Therapeutics, Inc, from SEC Form 4 filings since Jan 9, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -36%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | TARA Protara Therapeutics, Inc | Sold (not open market) | — |
| Jun 30, 2026 | TARA Protara Therapeutics, Inc | Sold (not open market) | — |
| Jun 30, 2026 | TARA Protara Therapeutics, Inc | Sold (not open market) | — |
| Jun 30, 2026 | TARA Protara Therapeutics, Inc | Sold (not open market) | — |
| Jun 29, 2026 | TARA Protara Therapeutics, Inc | Bought (not open market) | $412K |
| Jun 29, 2026 | TARA Protara Therapeutics, Inc | Sold | $882K |
| Jun 29, 2026 | TARA Protara Therapeutics, Inc | Bought (not open market) | — |
| Jan 26, 2026 | TARA Protara Therapeutics, Inc | Sold (not open market) | $58.2K |
| Jan 20, 2026 | TARA Protara Therapeutics, Inc | Sold (not open market) | $91.4K |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc | Bought (not open market) | — |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TARA Protara Therapeutics, Inc: 1 buy, 1 sale, last Jun 30, 2026